Page last updated: 2024-10-21

homovanillic acid and Bone Marrow Neoplasms

homovanillic acid has been researched along with Bone Marrow Neoplasms in 1 studies

Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.

Bone Marrow Neoplasms: Neoplasms located in the bone marrow. They are differentiated from neoplasms composed of bone marrow cells, such as MULTIPLE MYELOMA. Most bone marrow neoplasms are metastatic.

Research Excerpts

ExcerptRelevanceReference
"The value of the tumour markers vanillylmandelic acid (VMA) and homovanillic acid (HVA) in urine (u) and serum (s), neurone-specific enolase (NSE), and lactate dehydrogenase (LDH) in the early prediction of relapse/progression in neuroblastoma is not known."3.72Tumour markers are poor predictors for relapse or progression in neuroblastoma. ( Berthold, F; Hero, B; Hunneman, DH; Simon, T, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Simon, T1
Hero, B1
Hunneman, DH1
Berthold, F1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
PHASE III MULTICENTRE TRIAL OF TREATMENT OF NEUROBLASTOMA IN CHILDREN AND ADOLESCENTS[NCT00002802]Phase 3500 participants (Anticipated)Interventional1990-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for homovanillic acid and Bone Marrow Neoplasms

ArticleYear
Tumour markers are poor predictors for relapse or progression in neuroblastoma.
    European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:13

    Topics: Adolescent; Biomarkers, Tumor; Bone Marrow Neoplasms; Child; Child, Preschool; Clinical Trials as To

2003